Global Drugs for Malaria Competitive Landscape Professional Research Report 2024
Description
Global Drugs for Malaria Competitive Landscape Professional Research Report 2024
Research Summary
Drugs for malaria encompass a range of medications used to treat and prevent malaria, a life-threatening mosquito-borne disease caused by parasites of the Plasmodium genus. These drugs include antimalarial agents like chloroquine, artemisinin-based combination therapies (ACTs), mefloquine, atovaquone-proguanil, and others. The choice of drug depends on the specific Plasmodium species causing the infection and its resistance patterns. Antimalarials work by targeting different stages of the parasite＇s lifecycle within the human body. They can cure active infections and also be used as prophylaxis to prevent infection for individuals traveling to or residing in malaria-endemic regions. Due to the development of drug-resistant strains of the malaria parasite, treatment strategies may change over time, and healthcare professionals often follow updated guidelines to ensure effective management of the disease.
According to DIResearch's in-depth investigation and research, the global Drugs for Malaria market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.
The major global manufacturers of Drugs for Malaria include Cipla, Guilin Pharmaceutical, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Sanofi Aventis, Novartis, Ajanta Pharma etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Drugs for Malaria. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Drugs for Malaria market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Drugs for Malaria market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Drugs for Malaria industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Drugs for Malaria Include:
Cipla
Guilin Pharmaceutical
IPCA Laboratories
GlaxoSmithKline
Mylan Labs
Roche
Sanofi Aventis
Novartis
Ajanta Pharma
Drugs for Malaria Product Segment Include:
Aryl Aminoalcohol Compounds
Antifolate Compounds
Artemisinin Compounds
Drugs for Malaria Product Application Include:
Prevention
Treatment
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Drugs for Malaria Industry PESTEL Analysis
Chapter 3: Global Drugs for Malaria Industry Porter’s Five Forces Analysis
Chapter 4: Global Drugs for Malaria Major Regional Market Size and Forecast Analysis
Chapter 5: Global Drugs for Malaria Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Drugs for Malaria Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Drugs for Malaria Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Drugs for Malaria Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Drugs for Malaria Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Drugs for Malaria Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Drugs for Malaria Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Drugs for Malaria Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Drugs for Malaria Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Drugs for Malaria Product by Type
- 1.2.1 Global Drugs for Malaria Market Size by Type, 2023 VS 2024 VS 2030
- 1.2.2 Aryl Aminoalcohol Compounds
- 1.2.3 Antifolate Compounds
- 1.2.4 Artemisinin Compounds
- 1.3 Drugs for Malaria Product by Application
- 1.3.1 Global Drugs for Malaria Market Size by Application, 2023 VS 2024 VS 2030
- 1.3.2 Prevention
- 1.3.3 Treatment
- 1.3.4 Others
- 1.4 Global Drugs for Malaria Market Revenue Analysis (2019-2030)
- 1.5 Drugs for Malaria Market Development Status and Trends
- 1.5.1 Drugs for Malaria Industry Development Status Analysis
- 1.5.2 Drugs for Malaria Industry Development Trends Analysis
- 2 Drugs for Malaria Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Drugs for Malaria Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Drugs for Malaria Market Analysis by Regions
- 4.1 Drugs for Malaria Overall Market: 2023 VS 2024 VS 2030
- 4.2 Global Drugs for Malaria Revenue and Forecast Analysis (2019-2030)
- 4.2.1 Global Drugs for Malaria Revenue and Market Share by Region (2019-2024)
- 4.2.2 Global Drugs for Malaria Revenue Forecast by Region (2025-2030)
- 5 Global Drugs for Malaria Market Size by Type and Application
- 5.1 Global Drugs for Malaria Market Size by Type
- 5.2 Global Drugs for Malaria Market Size by Application
- 6 North America
- 6.1 North America Drugs for Malaria Market Size and Growth Rate Analysis (2019-2030)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Drugs for Malaria Market Size by Type
- 6.4 North America Drugs for Malaria Market Size by Application
- 6.5 North America Drugs for Malaria Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Drugs for Malaria Market Size and Growth Rate Analysis (2019-2030)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Drugs for Malaria Market Size by Type
- 7.4 Europe Drugs for Malaria Market Size by Application
- 7.5 Europe Drugs for Malaria Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Drugs for Malaria Market Size and Growth Rate Analysis (2019-2030)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Drugs for Malaria Market Size by Type
- 8.4 China Drugs for Malaria Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Drugs for Malaria Market Size and Growth Rate Analysis (2019-2030)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Drugs for Malaria Market Size by Type
- 9.4 APAC (excl. China) Drugs for Malaria Market Size by Application
- 9.5 APAC (excl. China) Drugs for Malaria Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Indonesia
- 9.5.6 Vietnam
- 9.5.7 Malaysia
- 9.5.8 Thailand
- 10 Latin America
- 10.1 Latin America Drugs for Malaria Market Size and Growth Rate Analysis (2019-2030)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Drugs for Malaria Market Size by Type
- 10.4 Latin America Drugs for Malaria Market Size by Application
- 10.5 Latin America Drugs for Malaria Market Size by Country
- 10.5.1 Mecixo
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Drugs for Malaria Market Size and Growth Rate Analysis (2019-2030)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Drugs for Malaria Market Size by Type
- 11.4 Middle East & Africa Drugs for Malaria Market Size by Application
- 11.5 Middle East & Africa Drugs for Malaria Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Market Competition by Manufacturers
- 12.1 Global Drugs for Malaria Market Revenue by Key Manufacturers (2020-2024)
- 12.2 Drugs for Malaria Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Drugs for Malaria Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Cipla
- 13.1.1 Cipla Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Cipla Drugs for Malaria Product Portfolio
- 13.1.3 Cipla Drugs for Malaria Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.2 Guilin Pharmaceutical
- 13.2.1 Guilin Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Guilin Pharmaceutical Drugs for Malaria Product Portfolio
- 13.2.3 Guilin Pharmaceutical Drugs for Malaria Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.3 IPCA Laboratories
- 13.3.1 IPCA Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 IPCA Laboratories Drugs for Malaria Product Portfolio
- 13.3.3 IPCA Laboratories Drugs for Malaria Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.4 GlaxoSmithKline
- 13.4.1 GlaxoSmithKline Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 GlaxoSmithKline Drugs for Malaria Product Portfolio
- 13.4.3 GlaxoSmithKline Drugs for Malaria Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.5 Mylan Labs
- 13.5.1 Mylan Labs Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Mylan Labs Drugs for Malaria Product Portfolio
- 13.5.3 Mylan Labs Drugs for Malaria Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.6 Roche
- 13.6.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Roche Drugs for Malaria Product Portfolio
- 13.6.3 Roche Drugs for Malaria Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.7 Sanofi Aventis
- 13.7.1 Sanofi Aventis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Sanofi Aventis Drugs for Malaria Product Portfolio
- 13.7.3 Sanofi Aventis Drugs for Malaria Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.8 Novartis
- 13.8.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Novartis Drugs for Malaria Product Portfolio
- 13.8.3 Novartis Drugs for Malaria Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.9 Ajanta Pharma
- 13.9.1 Ajanta Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Ajanta Pharma Drugs for Malaria Product Portfolio
- 13.9.3 Ajanta Pharma Drugs for Malaria Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 14 Industry Chain Analysis
- 14.1 Drugs for Malaria Industry Chain Analysis
- 14.2 Drugs for Malaria Industry Raw Material and Suppliers Analysis
- 14.2.1 Upstream Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Drugs for Malaria Typical Downstream Customers
- 14.4 Drugs for Malaria Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
